There may be significant differences between patients treated with POAC with oxaliplatin-based and fluoropyrimidine regimens in clinical practice, particularly for age, tumor aggressiveness, and patient status.
← all excerpts
Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis.
1
—
—